Ruqin Chen

Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer

Panos Fidias, Shaker R. Dakhil, Alan P. Lyss et al. · Journal of Clinical Oncology · 2008 · 422 citations · Full text

Medicine, Oncology, Pharmacology +15

A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer

Rafat Ansari, Mark A. Socinski, Martin J. Edelman et al. · Critical Reviews in Oncology/Hematology · 2010 · 50 citations

Medicine, Oncology, Pharmacology +14

Genomic landscape of lung adenocarcinomas in different races

Karan Seegobin, Fei Heng, Kexun Zhou et al. · Frontiers in Oncology · 2022 · 43 citations · Full text

Medicine, Genetics, Oncology +17

Association of Race, Socioeconomic Factors, and Treatment Characteristics With Overall Survival in Patients With Limited-Stage Small Cell Lung Cancer

Kexun Zhou, Ruqin Chen, Jordan J. Cochuyt et al. · JAMA Network Open · 2021 · 41 citations · Full text

Medicine, Biostatistics, Oncology +17

Outcomes Associated with Brain Metastases in a Three-Arm Phase III Trial of Gemcitabine-Containing Regimens Versus Paclitaxel Plus Carboplatin for Advanced Non-small Cell Lung Cancer

Martin J. Edelman, Chandra P. Belani, Mark A. Socinski et al. · Journal of Thoracic Oncology · 2010 · 38 citations

Medicine, Oncology, Pharmacology +16